Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh · Delayed Price · Currency is BDT 17.20
0.00 (0.00%)
At close: Jul 6, 2026
DSE:IBP Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Net Income | -14.39 | -36.83 | -40.98 | 8.41 | 25.17 | 134.73 |
Depreciation & Amortization | 27.98 | 28.46 | 28.54 | 38.36 | 39.13 | 35.9 |
Loss (Gain) From Sale of Assets | 6.06 | 6.06 | - | -0.7 | - | 0.77 |
Other Operating Activities | -23.3 | -22.93 | 14.32 | 21.4 | -1.54 | 7.69 |
Change in Accounts Receivable | -34.51 | 6.02 | 21.39 | -4.72 | 26.82 | -19.67 |
Change in Inventory | 82.85 | 57.89 | 17.02 | 2.47 | 21.01 | -11.8 |
Change in Accounts Payable | 4.33 | 17.62 | 0.02 | -0.09 | 0.31 | 0.25 |
Change in Other Net Operating Assets | 8.36 | 2.16 | -6.55 | 7.82 | -23.61 | 3.17 |
Operating Cash Flow | 57.38 | 58.45 | 33.77 | 72.95 | 87.28 | 151.02 |
Operating Cash Flow Growth | 317.08% | 73.09% | -53.71% | -16.42% | -42.20% | -13.96% |
Capital Expenditures | -0.56 | -0.56 | -10.13 | -30.03 | -39.68 | -200.41 |
Sale (Purchase) of Real Estate | - | - | - | -13.44 | -14.5 | - |
Investing Cash Flow | -0.56 | -0.56 | -10.13 | -43.47 | -54.18 | -200.41 |
Short-Term Debt Issued | - | - | - | - | - | 84.94 |
Total Debt Issued | - | - | - | - | - | 84.94 |
Short-Term Debt Repaid | - | -4.2 | -19.41 | -31.75 | -9.59 | - |
Total Debt Repaid | -1.85 | -4.2 | -19.41 | -31.75 | -9.59 | - |
Net Debt Issued (Repaid) | -1.85 | -4.2 | -19.41 | -31.75 | -9.59 | 84.94 |
Common Dividends Paid | -1.16 | -1.16 | -0.29 | -10.4 | -24.79 | -26.91 |
Other Financing Activities | -57.45 | -58.58 | -4.85 | -4.72 | -5.63 | - |
Financing Cash Flow | -60.46 | -63.94 | -24.55 | -46.87 | -40 | 58.03 |
Miscellaneous Cash Flow Adjustments | 0 | - | -0 | - | 0 | 13.11 |
Net Cash Flow | -3.64 | -6.05 | -0.91 | -17.39 | -6.9 | 21.75 |
Free Cash Flow | 56.82 | 57.89 | 23.64 | 42.92 | 47.6 | -49.39 |
Free Cash Flow Growth | 313.01% | 144.90% | -44.92% | -9.84% | - | - |
Free Cash Flow Margin | 23.47% | 31.43% | 13.38% | 11.46% | 9.82% | -6.31% |
Free Cash Flow Per Share | 0.49 | 0.50 | 0.20 | 0.37 | 0.41 | -0.43 |
Cash Interest Paid | 0.86 | 1.87 | 4.85 | 4.72 | 5.63 | - |
Cash Income Tax Paid | - | - | 3.6 | - | 13.72 | 16.35 |
Levered Free Cash Flow | 90.3 | 97.36 | 29.92 | 15.65 | 75.07 | -74.57 |
Unlevered Free Cash Flow | 90.64 | 98.53 | 32.67 | 18.92 | 78.12 | -72.19 |
Change in Working Capital | 61.04 | 83.7 | 31.89 | 5.48 | 24.52 | -28.06 |